{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:00:00Z","timestamp":1787742000412,"version":"build-2784847793"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:p>OBJECTIVE. Kernicterus is a rare but devastating condition. The prevention of bilirubin-induced brain injury is based on the detection of infants at risk for developing severe hyperbilirubinemia. In an 18-hospital health system, Intermountain Health Care (IHC), we initiated a program of predischarge bilirubin screening of all neonates and coupled this with a results assessment using a percentile-based nomogram. Data during 2 periods of time, before versus after initiating the program, were compared to assess the effect of the program on significant hyperbilirubinemia and rehospitalization.<\/jats:p>\n                  <jats:p>METHODS. We conducted a historic cohort study involving all neonates delivered at \u226535 weeks' gestation, within IHC's 18-hospital system, during 2 periods of time: March 1, 2001, to December 31, 2002, versus January 1, 2003, to December 31, 2004. A bilirubin screening program, instituted in December 2002, called for a total serum bilirubin (TSB) or transcutaneous bilirubin measurement to be performed on every neonate either at the recognition of clinical jaundice or before discharge regardless of whether jaundice was observed. For nonjaundiced neonates, the nursery staff was encouraged to obtain the screening TSB at the same time they obtained the state-mandated newborn screen for inborn errors of metabolism. Bilirubin values were plotted on an hour-specific nomogram and the corresponding percentile was used to guide evaluation, therapy, and follow-up. This study compared TSB data and readmission data for a 2-year period before versus a 2-year period after implementing the program.<\/jats:p>\n                  <jats:p>RESULTS. The study involved 101272 neonates: 48789 in period 1 and 52483 in period 2. Before the program, 1 in every 77 neonates born at an IHC hospital had 1 or more serum bilirubin levels &amp;gt;20 mg\/dL. After initiating the program, the incidence fell to 1 in 142 and the number of neonates with a level &amp;gt;25 mg\/dL fell from 1 in 1522 before to 1 in 4037 after. The rate of hospital readmission with a primary diagnosis of jaundice fell from 0.55% in period 1 to 0.43% in period 2.<\/jats:p>\n                  <jats:p>CONCLUSIONS. Initiating a program of bilirubin screening in a multihospital health system, coupled with evaluating the results using a percentile-based nomogram, reduced the proportion of neonates with significant hyperbilirubinemia and reduced the rate of hospital readmissions with jaundice.<\/jats:p>","DOI":"10.1542\/peds.2005-1338","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T13:22:05Z","timestamp":1146489725000},"page":"e855-e862","source":"Crossref","is-referenced-by-count":132,"title":["The Effect of Instituting a Prehospital-Discharge Newborn Bilirubin Screening Program in an 18-Hospital Health System"],"prefix":"10.1542","volume":"117","author":[{"given":"Larry D.","family":"Eggert","sequence":"first","affiliation":[{"name":"NICU Development Team, Intermountain Health Care, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Wiedmeier","sequence":"additional","affiliation":[{"name":"NICU Development Team, Intermountain Health Care, Salt Lake City, Utah"},{"name":"Department of Pediatrics, Division of Neonatology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janie","family":"Wilson","sequence":"additional","affiliation":[{"name":"NICU Development Team, Intermountain Health Care, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Christensen","sequence":"additional","affiliation":[{"name":"NICU Development Team, Intermountain Health Care, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,5,1]]},"reference":[{"key":"2021120823253090800_R1","doi-asserted-by":"crossref","unstructured":"Van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics.\u20081961;28:870\u2013876","DOI":"10.1542\/peds.28.6.870"},{"key":"2021120823253090800_R2","doi-asserted-by":"crossref","unstructured":"Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol.\u20081990;17:371\u2013379","DOI":"10.1016\/S0095-5108(18)30573-6"},{"key":"2021120823253090800_R3","doi-asserted-by":"crossref","unstructured":"Hsia DY-Y, Allen FH Jr, Gellis SS, Diamond LK. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med.\u20081952;247:668\u2013671","DOI":"10.1056\/NEJM195210302471802"},{"key":"2021120823253090800_R4","doi-asserted-by":"crossref","unstructured":"Johnstom WH, Angara V, Baumal R, et al. Erythroblastosis fetalis and hyperbilirubinemia: a five-year follow-up with neurological, psychological, and audiological evaluation. Pediatrics.\u20081967;39:88\u201392","DOI":"10.1542\/peds.39.1.88"},{"key":"2021120823253090800_R5","unstructured":"Bilirubin and brain injury. In: Volpe JJ, ed. Neonatal Neurology. Philadelphia, PA: WB Saunders; 2001:521\u2013546"},{"key":"2021120823253090800_R6","unstructured":"Brown AK, Johnson L. Loss of concern about jaundice and the reemergence of kernicterus in full-term infants in the era of managed care. In: Fanaroff AA, Klaus MH, eds. The Year Book of Neonatal and Perinatal Medicine. Philadelphia, PA: Mosby Yearbook; 1996:17\u201328"},{"key":"2021120823253090800_R7","doi-asserted-by":"crossref","unstructured":"Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics.\u20081994;93:1003\u20131006","DOI":"10.1542\/peds.93.6.1003"},{"key":"2021120823253090800_R8","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics.\u20081995;96:730\u2013733","DOI":"10.1542\/peds.96.4.730"},{"key":"2021120823253090800_R9","unstructured":"Sola A. Changes in clinical practice and bilirubin encephalopathy in \u201chealthy term newborns\u201d [abstract]. Pediatr Res.\u20081995;37:145"},{"key":"2021120823253090800_R10","doi-asserted-by":"crossref","unstructured":"MacDonald MG. Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics.\u20081995;96:734\u2013738","DOI":"10.1542\/peds.96.4.734"},{"key":"2021120823253090800_R11","doi-asserted-by":"crossref","unstructured":"Washington C, Ector W, Abbound K, Ohning B, Holding KR. Hemolytic jaundice due to G6PD deficiency causing kernicterus in newborn female. South Med J.\u20081995;88:776\u2013779","DOI":"10.1097\/00007611-199507000-00019"},{"key":"2021120823253090800_R12","doi-asserted-by":"crossref","unstructured":"Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr.\u20082000;89:1213\u20131217","DOI":"10.1111\/j.1651-2227.2000.tb00738.x"},{"key":"2021120823253090800_R13","doi-asserted-by":"crossref","unstructured":"Stanley TV. A case of kernicterus in New Zealand: a predictable tragedy?J Paediatr Child Health.\u20081997;33:451\u2013453","DOI":"10.1111\/j.1440-1754.1997.tb01641.x"},{"key":"2021120823253090800_R14","doi-asserted-by":"crossref","unstructured":"Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breast-fed term and near-term infants with marked hyperbilirubinemia. Pediatrics.\u20082001;107:1075\u20131080","DOI":"10.1542\/peds.107.5.1075"},{"key":"2021120823253090800_R15","unstructured":"Johnson L, Brown AK. A pilot registry for acute and chronic kernicterus in term and near-term infants [abstract]. Pediatrics.\u20081999;104:736"},{"key":"2021120823253090800_R16","doi-asserted-by":"crossref","unstructured":"Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr.\u20082002;140:396\u2013403","DOI":"10.1067\/mpd.2002.123098"},{"key":"2021120823253090800_R17","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol.\u20082004;24:650\u2013662","DOI":"10.1038\/sj.jp.7211152"},{"key":"2021120823253090800_R18","unstructured":"Joint Commission on Accreditation of Healthcare Organizations. Kernicterus threatens healthy newborns. Sentinel Event Alert.\u20082001;18:1\u20134"},{"key":"2021120823253090800_R19","unstructured":"Centers for Disease Control and Prevention. Kernicterus in full-term infants: United States, 1994\u20131998. MMWR Morb Mortal Wkly Rep.\u20082001;50:491\u2013494"},{"key":"2021120823253090800_R20","unstructured":"National Quality Forum. A national framework for healthcare quality measurement and reporting: a consensus report. Available at: www.qualityforum.org\/txframepublic.pdf. Accessed June 20, 2005"},{"key":"2021120823253090800_R21","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114:1138]. Pediatrics.\u20082004;114:297\u2013316","DOI":"10.1542\/peds.114.1.297"},{"key":"2021120823253090800_R22","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson L, Sivieri E. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics.\u20081999;103:6\u201314","DOI":"10.1542\/peds.103.1.6"},{"key":"2021120823253090800_R23","doi-asserted-by":"crossref","unstructured":"Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med.\u20082000;154:1140\u20131147","DOI":"10.1001\/archpedi.154.11.1140"},{"key":"2021120823253090800_R24","doi-asserted-by":"crossref","unstructured":"Alpay F, Sarici SU, Tosuncuk HD, Serdar MA, Inanc N, Gokcay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics.\u20082000;106:1\u20136","DOI":"10.1542\/peds.106.2.e16"},{"key":"2021120823253090800_R25","doi-asserted-by":"crossref","unstructured":"Stevenson DK, Fanaroff A, Maisels J, et al. Prediction of hyperbilirubinemia in term and near-term newborn infants. Pediatrics.\u20082001;108:31\u201339","DOI":"10.1542\/peds.108.1.31"},{"key":"2021120823253090800_R26","doi-asserted-by":"crossref","unstructured":"Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med.\u20082001;344:581\u2013590","DOI":"10.1056\/NEJM200102223440807"},{"key":"2021120823253090800_R27","doi-asserted-by":"crossref","unstructured":"Braveman P, Egerter S, Pearl M, Marchi K, Miller C. Problems associated with early discharge of newborn infants: early discharge of newborns and mothers. A critical review of the literature. Pediatrics.\u20081995;96:716\u2013726","DOI":"10.1542\/peds.96.4.716"},{"key":"2021120823253090800_R28","doi-asserted-by":"crossref","unstructured":"Britton JR, Britton HL, Beebe SA. Early discharge of the term newborn: a continued dilemma. Pediatrics.\u20081994;94:291\u2013295","DOI":"10.1542\/peds.94.3.291"},{"key":"2021120823253090800_R29","doi-asserted-by":"crossref","unstructured":"Watchko JF, Oski FA. Bilirubin 20 mg\/dL = vigintiphobia. Pediatrics.\u20081983;71:660\u2013663","DOI":"10.1542\/peds.71.4.660"},{"key":"2021120823253090800_R30","doi-asserted-by":"crossref","unstructured":"Newman TB, Masisel MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants. Clin Perinatol.\u20081990;17:331\u2013357","DOI":"10.1016\/S0095-5108(18)30571-2"},{"key":"2021120823253090800_R31","doi-asserted-by":"crossref","unstructured":"Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics.\u20081992;89:809\u2013818","DOI":"10.1542\/peds.89.5.809"},{"key":"2021120823253090800_R32","unstructured":"Oski A. Hyperbilirubinemia in the term infant: an unjaundiced approach. Contemp Pediatr.\u20081992;April:148\u2013152"},{"key":"2021120823253090800_R33","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Provisional Committee for Quality Improvement. Practice parameter: management of hyperbilirubinemia in the healthy term newborn [published correction appears in Pediatrics. 1995;95:458\u201361]. Pediatrics.\u20081994;94:558\u2013565","DOI":"10.1542\/peds.94.4.558"},{"key":"2021120823253090800_R34","doi-asserted-by":"crossref","unstructured":"Maisel MJ, Newman TB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics.\u20081999;103:493\u2013495","DOI":"10.1542\/peds.103.2.493"},{"key":"2021120823253090800_R35","doi-asserted-by":"crossref","unstructured":"Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics.\u20081999;104:1198\u20131203","DOI":"10.1542\/peds.104.S6.1198"},{"key":"2021120823253090800_R36","doi-asserted-by":"crossref","unstructured":"Lee KS, Perlman M, Ballantyne M, Elliott I. Association between duration of neonatal hospital stay and readmission rate. J Pediatr.\u20081995;127:758\u2013766","DOI":"10.1016\/S0022-3476(95)70170-2"},{"key":"2021120823253090800_R37","doi-asserted-by":"crossref","unstructured":"Grupp-Phelan J, Taylor JA, Liu LL, Davis RL. The effect of early discharge and other factors on readmission rates of newborns. Arch Pediatr Adolesc Med.\u20081999;153:1283\u20131288","DOI":"10.1001\/archpedi.153.12.1283"},{"key":"2021120823253090800_R38","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics.\u20081998;101:995\u2013998","DOI":"10.1542\/peds.101.6.995"},{"key":"2021120823253090800_R39","doi-asserted-by":"crossref","unstructured":"Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics.\u20082004;113:775\u2013780","DOI":"10.1542\/peds.113.4.775"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/5\/e855\/1070724\/zpe0050600e855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/5\/e855\/1070724\/zpe0050600e855.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T04:37:16Z","timestamp":1683434236000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/5\/e855\/70030\/The-Effect-of-Instituting-a-Prehospital-Discharge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,5,1]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1338","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}